Saudi Arabia will begin inoculating children aged 5 to 11 years using Pfizer-BioNTech, the kingdom’s Food and Drug Authority announced on Wednesday.
The decision “was based on the data provided by the company”, the FDA said, citing studies on the effectiveness of the vaccine in this age group.
Over 46 million doses of COVID-19 vaccines have been administered in the Kingdom to date, with 62% of the population vaccinated, according to Our World in Data.
Fellow gulf country Bahrain has also announced earlier this week that it’ll begin administering Pfizer jabs to the same age category.
The American Centers for Disease Control and Prevention (CDC) yesterday gave approval for Pfizer’s pediatric shots, allowing many children across the US to get vaccinated.
According to data released by Pfizer on October 22, the vaccine offers strong protection for this age group, with a 90.7 percent efficacy rate in preventing symptomatic infections.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.